David P. Schenkein
Chairman
Agios Pharmaceuticals, Inc. (AGIO)Equibles does not estimate personal net worth.
Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AGIO alertsAbout David P. Schenkein
David P. Schenkein is recorded as Chairman at Agios Pharmaceuticals, Inc. (AGIO). The newest filing on record that lists David P. Schenkein as Chairman at Agios Pharmaceuticals, Inc. (AGIO) is dated April 8, 2021. Agios Pharmaceuticals, Inc. reported in an 8-K filed February 13, 2025 that David P. Schenkein resigned as Board of Directors, effective February 28, 2025. The proxy statement of Agios Pharmaceuticals, Inc. reports total compensation of $2,576,376 for David P. Schenkein in fiscal 2019, including a base salary of $212,500. Disclosed compensation is on record for 3 fiscal years. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), Jacqualyn A. Fouse (Chairman) and 7 others.
“On February 10, 2025, David P. Schenkein, M.D., notified Agios Pharmaceuticals, Inc. (the "Company") of his decision to resign from the Board of Directors of the Company (the "Board"), effective February 28, 2025.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 8, 2021
-
Agios Pharmaceuticals, Inc. (AGIO)
Proxy statement
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2025-02-28
Company network
Leadership on record at Agios Pharmaceuticals, Inc.
- Brian Goff CEO, Board Member
- Jacqualyn Fouse CEO, Board Member
- Jacqualyn A. Fouse Chairman
- Cecilia Jones CFO
- T.J. Washburn Chief Accounting Officer
- Catherine Owen Adams Board Member
- Cynthia Smith Board Member
- David Scadden Board Member
- David Scadden, M.D. Board Member
- Jacqualyn A. Fouse, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | Former President and ChiefExecutiveOfficer;Executive Chairman | $212,500 | $2,576,376 |
| 2018 | Agios Pharmaceuticals, Inc. (AGIO) | Former President and ChiefExecutiveOfficer;Executive Chairman | $625,000 | $8,199,324 |
| 2017 | Agios Pharmaceuticals, Inc. (AGIO) | Former President and ChiefExecutiveOfficer;Executive Chairman | $585,040 | $5,972,364 |